13.6 C
London
Monday, October 3, 2022

Medtech Nutromics raises $20.5 million for wearable diagnostic device

Must read

Right-wing disinformation is on the rise on WeChat ahead of midterm exams, report says

Disinformation saturates the widely used social media platform WeChat and poses a growing threat to Chinese-American voters in November's midterm elections, a new report...

Twitter extends access to the experimental status feature… but not for paid subscribers • londonbusinessblog.com

Twitter's throwback feature, Twitter Status, is expanding its list of potential status updates to choose from today, in a continuation of testing that began...

I will defend the $700 million carbonated water • londonbusinessblog.com

The crazy season is over in venture capital country. Today investors and founders alike will bore your ears with notes about: incremental cash flow positivity...

Limit reached – Join the EU Startups CLUB

€147/quarter This option is ideal for companies and investors who want to keep up to date with Europe's most promising startups, have full access...
Shreya Christinahttps://londonbusinessblog.com
Shreya has been with londonbusinessblog.com for 3 years, writing copy for client websites, blog posts, EDMs and other mediums to engage readers and encourage action. By collaborating with clients, our SEO manager and the wider londonbusinessblog.com team, Shreya seeks to understand an audience before creating memorable, persuasive copy.

Melbourne Medtech startup Nutromics has raised $14 million (A$20.5 million) for its wearable diagnostic platform as it plans to ramp up its expansion in Australia and the US.

The round was led by the venture arm of US medical device company Dexcom, along with VU Venture Partners and Artesian Investments.

Nutronics has raised more than $20 million (A$29 million) since its inception in 2017, including a $2 million federal government grant as part of the Co-operative Research Centers Projects program.

A serial backer, Atersian led a $5.7 million round in August 2021 and is now making his fourth investment in the medtech startup.

The portable Nutronics device.

The new capital will support an expansion of clinical studies, expansion of the R&D team and investments in both the Australian and US hubs, while clinical trials of the device are currently underway in partnership with Monash University.

Nutromics is developing a wearable diagnostic platform that uses DNA technology to track multiple targets in the human body with a single patch.

The breakthrough DNA sensor will provide clinicians and patients with continuous and real-time diagnostic information ranging from difficult-to-dose drugs, such as vancomycin, to biological markers for conditions such as kidney disease.

The company hopes to launch its device in Australia and the US by 2023 before expanding globally.

Co-founder and CEO Peter Vranes said the company will be looking for “significantly more funding in 2023” following the in vivo (in the body) clinical trials of its device, which provides continuous diagnostic monitoring.

“We are pursuing a paradigm shift in diagnostic health care by essentially developing a lab-on-a-patch,” he said.

“A lack of timely and continuous diagnostic insights can have a major impact on outcomes in managing critical disease states. With this strategic industry and VC investment in us, we see greater confidence in our technology and hope to accelerate our growth, as the need for our platform in the diagnostic lab space is urgent.”

Vranes and his co-founder Hitesh Mehta are also seeking government support to build a $60 million state-of-the-art manufacturing facility for their product here in Australia.

 

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Right-wing disinformation is on the rise on WeChat ahead of midterm exams, report says

Disinformation saturates the widely used social media platform WeChat and poses a growing threat to Chinese-American voters in November's midterm elections, a new report...

Twitter extends access to the experimental status feature… but not for paid subscribers • londonbusinessblog.com

Twitter's throwback feature, Twitter Status, is expanding its list of potential status updates to choose from today, in a continuation of testing that began...

I will defend the $700 million carbonated water • londonbusinessblog.com

The crazy season is over in venture capital country. Today investors and founders alike will bore your ears with notes about: incremental cash flow positivity...

Limit reached – Join the EU Startups CLUB

€147/quarter This option is ideal for companies and investors who want to keep up to date with Europe's most promising startups, have full access...

Victoria has $10 million to solve one of the biggest recycling problems of the next decade: solar panels

A $10 million program has been launched in Victoria to tackle solar panel recycling. Breakthrough Victoria, a company that manages a $2 billion fund set...